Sandra Pratt

Sandra Pratt discloses dealings in Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) to SEDI. In total, 5 filings cover trades dated from 16 January 2015 to 15 December 2016.

In open-market terms, that means 2 purchases on one side and 2 sales on the other. The totals do not cover 4 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2016: 2 purchases and 2 sales on the market.

The latest filing, published on 19 December 2016, reports an open-market sale in Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.). The most recent open-market purchase was published on 19 December 2016, 3,597 days ago. The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.